内視鏡的血管採取装置の世界市場-2023年～2030年

概要

冠動脈バイパス術で最も頻繁に使用される導管である大伏在静脈（GSV）は、内視鏡的静脈採取（EVH）法で採取されます。この手術では、小さな切開創と内視鏡カメラを用い、皮下に皮下組織のトンネルを作ります。この実習では、手術の重要な手順と、それを行う医療チームの責任について説明します。

血管採取手技の視野の質、器具の可動性、そして一般的な有効性はすべて、内視鏡技術の継続的な発展の結果として向上しています。内視鏡下血管採取術は、これらの開発により、より安全で効率的なものとなっています。切開創が小さく、瘢痕が少なく、回復が早いといった低侵襲手術の利点が認識され、より多くの患者が低侵襲手術を希望しています。患者のニーズに合わせて、外科医は内視鏡的血管採取装置を使用する可能性が高まっています。

市場力学：促進要因

冠動脈バイパス移植（CABG）手術の需要増加

冠動脈バイパス移植（CABG）手術で最も頻繁に使用される導管である大伏在静脈（GSV）は、過去10年間、内視鏡的静脈採取（EVH）によって採取されてきました。その長さと採取の簡便さから、伏在静脈は頻繁に利用されています。患者の間で冠動脈バイパス手術の必要性が高まり、CABG手術の世界の需要が高まった結果、より多くの優れた導管の必要性が高まっています。

主要企業は、市場における器具の需要を満たすために製品を提供しています。例えば、Vasoview Hemopro 2内視鏡下血管採取（EVH）システムは、人間工学に基づいた最先端のデザインが特徴です。これは伏在静脈と橈骨動脈の両方の血管採取のための業界標準であり、優れた操作性と優れた可視性を提供し、より良い患者の転帰のために、採取者がより生産的かつ効果的に作業できるようにします。

さらに、低侵襲手術の際には、Saphena Medical Venapax内視鏡下血管採取システムの使用が推奨されます。主に動脈バイパスのための内視鏡手術を受ける患者に、血管採取へのアクセスを提供します。冠動脈バイパス移植術のための伏在静脈に沿った組織剥離、冠動脈バイパス移植術のための末梢動脈バイパスまたは橈骨動脈は、四肢の手術の例です。

心血管疾患の有病率の増加

世界保健機関（WHO）によると、年間1,790万人が死亡しており、心血管系疾患（CVD）は世界の死亡原因の第1位です。冠動脈性心疾患、脳血管疾患、リウマチ性心疾患などがCVDと呼ばれる心臓や血管の疾患のカテゴリーに含まれます。CVDによる死亡者の5人に4人以上が心臓発作と脳卒中であり、その3分の1が70歳までに死亡しています。

さらに、心血管疾患の治療における技術的進歩が市場を牽引しています。例えば、2023年のJournal of Visualized Surgeryによると、過去数十年間、冠動脈手術は著しい発展を遂げてきました。これらの開発の多くは、患者のためのグラフト開存性を改善し、心臓手術の罹患率を減少させました。ロボット完全内視鏡下冠動脈バイパス術（TECAB）は、外科医が外科用ロボットを用いて、内視鏡によるポート部切開を行い、吻合部の縫合を含むすべての主要な手術工程を完了させる治療法です。

抑制要因

内視鏡下血管採取装置市場は成長を遂げる一方で、その市場開拓と普及を妨げる様々な抑制要因にも直面しています。例えば、デバイスの高コスト、熟練外科医の不足、安全性への懸念、代替技術、規制上のハードル、限られた臨床エビデンスなどです。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 冠動脈バイパス術（CABG）需要の増加
    • 心血管疾患の有病率の増加
  • 抑制要因
    • 高コスト
    • 熟練外科医の不足
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• ロシア・ウクライナ戦争の影響分析
• SWOT分析
• 特許分析
• DMIオピニオン

第6章 COVID-19分析

第7章 製品タイプ別

• EVHシステム
• アクセサリー
• その他

第8章 用途別

• 冠動脈バイパス術（CABG）
• 末梢動脈バイパス手術

第9章 エンドユーザー別

• 病院
• 外来手術センター（ASCs）
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市場ポジショニング/シェア分析
• M&A分析

第12章 企業プロファイル

• Getinge
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Spectra Group
• Terumo Corporation
• KARL STORZ SE & Co. KG
• Saphena Medical
• Medical Instruments Spa
• Sorin Group
• Medical Instruments Spa
• Med Europe S.r.l.
• Olympus Corporation

第13章 付録

Overview

The greater saphenous vein (GSV), the conduit most frequently utilized in coronary artery bypass graft surgery, is harvested via an endoscopic vein harvesting (EVH) method. A subcutaneous tissue tunnel is made under the skin utilizing tiny incisions and an endoscopic camera that resembles a blunt dissector to execute this surgery. The exercise describes the procedure's essential steps as well as the responsibilities of the medical team performing it.

The quality of vision, instrument mobility, and general effectiveness of vessel harvesting procedures have all increased as a result of ongoing developments in endoscopic technology. Endoscopic vessel harvesting is now safer and more efficient thanks to these developments. The perceived advantages of minimally invasive surgical procedures, such as smaller incisions, less scarring, and speedier recovery, are leading more patients to ask for them. To suit patient needs, surgeons are increasingly likely to use endoscopic vascular harvesting devices.

Market Dynamics: Drivers

Increasing Demand Coronary Artery Bypass Graft (CABG) Surgery

The greater saphenous vein (GSV), which is the most often used conduit in coronary artery bypass graft (CABG) surgery, has been harvested via endoscopic vein harvesting (EVH) over the past ten years. Due to their length and simplicity of harvesting, the saphenous veins are frequently exploited. The need for more and better conduits has grown as a result of the rising necessity for numerous coronary artery bypass surgeries among patients and the global demand for CABG operations.

The key players are offering the product to meet the demand of devices in the market. For instance, the Vasoview Hemopro 2 Endoscopic Vessel Harvesting (EVH) System features the most advanced ergonomic design available. It is the industry standard for both saphenous vein and radial artery vessel harvesting, offering great maneuverability and superb visibility to let harvesters work more productively and effectively for better patient outcomes.

In addition, it is recommended to use the Saphena Medical Venapax endoscopic vessel harvesting system during minimally invasive surgery. Primarily for patients undergoing endoscopic surgery for artery bypass, giving access to vascular harvesting. Tissue dissection along the saphenous vein for coronary artery bypass grafting and peripheral artery bypass or radial artery for coronary artery bypass grafting are examples of extremity surgeries.

The Increasing Prevalence of Cardiovascular diseases

According to World Health Organization, with 17.9 million deaths per year, cardiovascular diseases (CVDs) are the leading cause of death worldwide. Coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other illnesses are among the category of heart and blood vessel disorders known as CVDs. Heart attacks and strokes account for more than four out of every five CVD deaths, and one-third of these deaths happen before the age of 70.

In addition, the technological advances in the treatment of cardiovascular disease drive the market. For instance, as per the Journal of Visualized Surgery in 2023, Over the past few decades, coronary artery surgery has undergone significant development. Numerous of these developments have improved graft patency for patients and reduced the morbidity of cardiac surgery. Robotic completely endoscopic coronary artery bypass (TECAB) grafting is a treatment in which surgeons use a surgical robot to complete all major surgical processes, including anastomotic suturing, using endoscopic port site incisions.

Restraining Factors

The endoscopic vessel harvesting devices market, while experiencing growth, also faces various restraint factors that can hinder its development and adoption. The factors such as high cost of devices, lack of skilled surgeons, safety concerns, alternative techniques, regulatory hurdles, and limited clinical evidence.

Segment Analysis

The global endoscopic vessel harvesting devices market is segmented based on product type, application, end-user and region.

The EVH Systems segment accounted for approximately 45.8% of the market share

The greater saphenous vein (GSV), the conduit most frequently used in coronary artery bypass graft surgery, is harvested via an endoscopic vein harvesting (EVH) method. An endoscopic camera, such as a blunt dissector, must be used in conjunction with minor incisions to create a tunnel of subcutaneous tissue beneath the skin during this surgery. The activity outlines the procedure's essential steps and clarifies the roles of the healthcare team doing it.

By employing an endoscope to view the patient's body, endoscopic tools enable clinicians to carry out minimally invasive surgeries through very small incisions. When performing cardiac surgery, the VirtuoSaph Plus Endoscopic Vessel Harvesting System from Terumo is utilized to remove the patient's saphenous vein or radial artery for use as a bypass graft.

Geographical Penetration

North America segment accounted for approximately 38.6% of the market share

North America has been a dominant force in the global endoscopic vessel harvesting devices market. Infections at the sternal or conduit harvest site incisions were thought to have occurred in between 2% and 20% of coronary artery bypass grafting (CABG) surgeries performed in the United States. Although graft harvest site infections may be more frequent after CABG, deep chest infections and mediastinitis have received a lot of attention due to their potential for significant morbidity and mortality.

Gintage offers Early generation EVH users were taken into consideration during the design of the Vasoview 7xB Endoscopic Vessel Harvesting System. The 7xB platform, with its cutting-edge, responsive controls, enables you to work with confidence and enjoy quick productivity if you are most comfortable using a two-handed configuration.

As of July 2023, CardioPrecision, an expert in transcervical access for the treatment of structural heart disease and cardiothoracic interventions, has taken another significant step by entering the US market, which is currently the largest medical device market by value in the world and represents a significant scale up for the company. This comes after its CoreVista devices were proven to be highly effective in Scotland.

CardioPrecision, a company that was spun off from the NHS through InnoScot Health, recently debuted its technology at the prestigious Massachusetts General Hospital in Boston for use in Endoscopic Vessel Harvesting (EVH) during coronary artery bypass grafting (CABG) operations.

COVID-19 Impact Analysis:

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global endoscopic vessel harvesting devices market. In order to conserve resources and reduce the risk of infection for both patients and healthcare professionals during the height of the epidemic, numerous hospitals and healthcare facilities postponed or cancelled elective surgery.

As a result, there were significantly fewer procedures involving coronary artery bypass grafting (CABG), which in turn reduced the demand for endoscopic vascular harvesting equipment.

Competitive Landscape

The major global players in the market include: Getinge, Spectra Group, Terumo Corporation, KARL STORZ SE & Co. KG, Saphena Medical, Medical Instruments Spa, Sorin Group, Medical Instruments Spa, Med Europe S.r.l., and Olympus Corporation among others.

Why Purchase the Report?

• To visualize the global endoscopic vessel harvesting devices market segmentation based on product type, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of endoscopic vessel harvesting devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global endoscopic vessel harvesting devices market report would provide approximately 61 tables, 56 figures and 186 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Application
• 3.3. Snippet by End-user
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Demand Coronary Artery Bypass Graft (CABG) Surgery
    • 4.1.1.2. The Increasing Prevalence of Cardiovascular Diseases
  • 4.1.2. Restraints
    • 4.1.2.1. High Cost
    • 4.1.2.2. Lack of Skilled Surgeons
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Russia-Ukraine War Impact Analysis
• 5.6. SWOT Analysis
• 5.7. Patent Analysis
• 5.8. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. EVH Systems*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Accessories
• 7.4. Others

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Coronary Artery Bypass Grafting (CABG)*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Peripheral Artery Bypass Surgery

9. By End-user

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
  • 9.1.2. Market Attractiveness Index, By End-user
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Ambulatory Surgical Centers (ASCs
• 9.4. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Getinge*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Spectra Group
• 12.3. Terumo Corporation
• 12.4. KARL STORZ SE & Co. KG
• 12.5. Saphena Medical
• 12.6. Medical Instruments Spa
• 12.7. Sorin Group
• 12.8. Medical Instruments Spa
• 12.9. Med Europe S.r.l.
• 12.10. Olympus Corporation

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us